- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 182.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 182.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 175.79M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$25.47K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$16.09K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $62 |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.14K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $23.03K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $54 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.32M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$1.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$1.06M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.28M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.28M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.11M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.82M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $46.59K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $15.46K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$44.67K |
| Net Income | Q1 2026 · Dec 31, 2025 | −$335.37K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$81.19K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$141.88K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$100.09K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $0 |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $0 |